7 FDA-Regulated Clinical Research

1Darshan Kulkarni, Pharm.D, MS, Esq. is the Vice President of Regulatory Strategy and Policy at Synchrogenix in Philadelphia, PA. He is responsible in guiding the policy development and engagement strategies of the company using various methodologies including, but not limited to, artificial intelligence, blockchain, and big data. He has multiple patent filings to his name and owns various forms of intellectual property rights including copyrights and trademarks.